Global Prosthetic Joint Infection Market to Grow Owing to rising number of joint replacement surgeries

Global Prosthetic Joint Infection Market to Grow Owing to rising number of joint replacement surgeries

Prosthetic joints offer enhanced mobility and reduce pain for patients suffering from severe joint disorders like arthritis. Made of durable metal alloys and plastics, artificial joints replace damaged wrist, shoulder, knee or hip joints. However, prosthetic joint infections caused by bacteria and fungi post-surgery can lead to implant failure and recurrence of disability. The global prosthetic joint infection market consists of antibiotic drugs and surgical procedures to treat infected implants. Antibiotics like vancomycin and daptomycin are commonly prescribed to eliminate biofilm layers formed by pathogens on implant surfaces. Sometimes parts or the entire prosthesis needs to be surgically removed and replaced to eradicate an infection.

The prosthetic joint infection market is estimated to be valued at USD 64.2 Mn in 2024 and is expected to reach USD 91.6 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

Key Takeaways

Key players operating in the prosthetic joint infection market include Bayer AG, Cempra Inc., Berkshire Sterile Manufacturing, and Telephus Medical LLC. With rising joint replacement volumes, the demand for infection prevention and treatment solutions is surging. Staphylococcus aureus and Staphylococcus epidermidis are the most common bacteria identified in infected implants. Leading market participants are focusing on developing antibacterial coatings and advanced diagnostic tools to identify biofilm formation at early stages.

Knee and hip replacement surgeries have doubled in the last decade globally due to increasing obese population and higher life expectancy. With volume growth, risks of post-surgical complications including prosthetic joint infections are also rising.

The Prosthetic Joint Infection Market major players are investing in combination therapy prototypes involving antibiotic-eluting implants and complementary oral/IV drugs. Advanced imaging solutions allowing surgeons to visualize biofilms non-invasively can aid clinical decision making and optimize treatment outcomes.

Market Trends
Outpatient joint replacement surgery - To reduce healthcare costs, hospitals are performing more arthroplasty procedures in outpatient settings. However, recovering patients may face higher infection risks at home initially due to lack of sterility.

Personalized antibacterial solutions - With greater understanding of pathogenesis, targeted drugs formulations against resistant bacteria strains causing chronic/recurring PJI are under development. Biomaterial companies are also exploring patient-specific implant coatings.

Market Opportunities
Emerging economies - Joint replacement volumes in Asia Pacific and Latin America will surge dramatically through 2030. While pose challenges, massive patient bases also offer scope for affordable infection prevention solutions catering to local needs.

Prevention initiatives - Strict sterile protocols during surgery can curb 50% PJI cases. Investor focus on compliance monitoring tools, antibacterial drapes and prophylactic treatments present opportunities for stakeholders.

Here is 300 words on the impact of COVID-19 on the prosthetic joint infection market
The COVID-19 pandemic has significantly impacted the prosthetic joint infection market. During the peak of the pandemic in 2020, most elective surgeries including joint replacement procedures were postponed to avoid overwhelming healthcare resources and reduce exposure risk for vulnerable patients undergoing surgery. This led to a steep decline in the number of joint replacement procedures performed globally. As a result, the demand for therapies and drugs to treat prosthetic joint infections also reduced substantially during this period.

However, as the pandemic is brought under better control in 2021 with increased vaccination rates, the number of joint replacement surgeries has begun increasing once more. While backlogs still exist, most clinics and hospitals have resumed elective orthopedic procedures with strict safety protocols. This revival in joint replacement volume is driving the prosthetic joint infection market towards recovery. Yet, risks of virus transmission within healthcare settings continue to remain a challenge. Telemedicine and remote monitoring are playing a larger role in post-surgery follow ups to minimize physical visits to clinics. New antibiotic and anti-microbial coating technologies focused on reducing infection risks are also gaining more attention among orthopedic product developers. Overall, while the COVID-19 crisis severely impacted the market in the short-term, focus on new prevention strategies and steady increase in surgery numbers indicate a gradual rise in demand over the coming years.

In terms of geography, North America accounts for the largest share of the global prosthetic joint infection market currently. The region has advanced healthcare infrastructure and high rates of hip and knee replacement procedures performed annually. Additionally, growing elderly population suffering from arthritis and favorable reimbursement policies have further augmented regional market opportunities. Meanwhile, Asia Pacific is projected as the fastest growing regional market owing to rising health expenditures, increasing medical tourism and an overhaul of public healthcare systems across developing nations. China, India and South Korea specifically are developing rapidly into high potential markets. Improving standards of orthopedic care and rising incidence of bone infections fuel regional market demand.

Get More Insights On- Prosthetic Joint Infection Market

Get This Report in Japanese Language: 人工関節感染症市場

Get This Report in Korean Language: 인공관절 감염 시장

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.

(https://www.linkedin.com/in/ravina-pandya-1a3984191)